MBX Biosciences, Inc. (MBX)
32.29
+2.44
(+8.17%)
USD |
NASDAQ |
Apr 01, 16:00
32.05
-0.24
(-0.74%)
Pre-Market: 08:51
MBX Biosciences EPS Diluted (Quarterly) : -0.4917 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orthofix Medical, Inc. | -0.0555 |
| Arcutis Biotherapeutics, Inc. | 0.1282 |
| Genelux Corp. | -0.2452 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.06M |
| Total Expenses (Quarterly) | 22.06M |
| Enterprise Value | 1.161B |
| Earnings Yield | -6.92% |
| Normalized Earnings Yield | -6.921 |